Literature DB >> 10533311

Intermediary signaling effectors coupling the B-cell receptor to the nucleus.

M R Gold1.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10533311     DOI： 10.1007/978-3-642-57066-7_3

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  7 in total

Review 1.  Ligand-dependent and -independent processes in B-cell-receptor-mediated signaling.

Authors:  E M Fuentes-Pananá; J G Monroe
Journal:  Springer Semin Immunopathol       Date:  2001-12

2.  Inducible gene deletion reveals different roles for B-Raf and Raf-1 in B-cell antigen receptor signalling.

Authors:  Tilman Brummer; Peter E Shaw; Michael Reth; Yukiko Misawa
Journal:  EMBO J       Date:  2002-11-01       Impact factor: 11.598

3.  Prolyl 4-hydroxylase 2 promotes B-cell lymphoma progression via hydroxylation of Carabin.

Authors:  Wei Jiang; Xiaoyan Zhou; Zengxia Li; Kaiyu Liu; Weige Wang; Renke Tan; Xiaoji Cong; Jiaoyu Shan; Yanxia Zhan; Zhaomeng Cui; Lizhi Jiang; Quanfu Li; Suqin Shen; Meirong Bai; Yunfeng Cheng; Bin Li; Minjia Tan; Dengke K Ma; Jun O Liu; Yongjun Dang
Journal:  Blood       Date:  2018-02-01       Impact factor: 22.113

4.  TAPP1 and TAPP2 are targets of phosphatidylinositol 3-kinase signaling in B cells: sustained plasma membrane recruitment triggered by the B-cell antigen receptor.

Authors:  Aaron J Marshall; Allyson K Krahn; Kewei Ma; Vincent Duronio; Sen Hou
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

5.  EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression.

Authors:  Ilaria Guasparri; Darya Bubman; Ethel Cesarman
Journal:  Blood       Date:  2008-01-29       Impact factor: 22.113

6.  Vav3 modulates B cell receptor responses by regulating phosphoinositide 3-kinase activation.

Authors:  Kazunori Inabe; Masamichi Ishiai; Andrew M Scharenberg; Norman Freshney; Julian Downward; Tomohiro Kurosaki
Journal:  J Exp Med       Date:  2002-01-21       Impact factor: 14.307

7.  Kidins220/ARMS binds to the B cell antigen receptor and regulates B cell development and activation.

Authors:  Gina J Fiala; Iga Janowska; Fabiola Prutek; Elias Hobeika; Annyesha Satapathy; Adrian Sprenger; Thomas Plum; Maximilian Seidl; Jörn Dengjel; Michael Reth; Fabrizia Cesca; Tilman Brummer; Susana Minguet; Wolfgang W A Schamel
Journal:  J Exp Med       Date:  2015-08-31       Impact factor: 14.307
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.